相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
VX-770
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
873054-44-5
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥432.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥250.0 |
| 规格: | 5 mg | 产品价格: | ¥500.0 |
| 规格: | 10 mg | 产品价格: | ¥750.0 |
| 规格: | 25 mg | 产品价格: | ¥1238.0 |
| 规格: | 50 mg | 产品价格: | ¥1733.0 |
| 规格: | 100 mg | 产品价格: | ¥2426.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Ivacaftor
CAS No. : 873054-44-5
MCE 国际站:Ivacaftor
产品活性:Ivacaftor (VX-770) 是一种有效可口服的 CFTR 增效剂,靶向G551D-CFTR和F508del-CFTR的EC50分别为100 nM 和 25 nM。
研究领域:Membrane Transporter/Ion Channel | Autophagy
In Vitro: Ivacaftor (10 µM) increases the PC secretion activity by 3-fold for ABCB4-G535D, 13.7-fold for ABCB4-G536R, 6.7-fold for ABCB4-S1076C, 9.4-fold for ABCB4-S1176L, and 5.7-fold for ABCB4-G1178S. Ivacaftor corrects the functional defect of ABCB4 mutants. Ivacaftor (10 μM) significantly increases CFTR activity in W1282X-expressing cells compared to R1162X CFTR cells. Ivacaftor shows no significant activity against 160 targets tested including the GABAA benzodiazepine receptor. Ivacaftor increases the chloride secretion with an EC50 of 0.236 ± 0.200 μM, a 10-fold shift in potency compared to the F508del HBEs. In recombinant cells, VX-770 increases CFTR channel open probability (Po) in both the F508del processing mutation and the G551D gating mutation. VX-770 increases forskolin-stimulated IT in temperature-corrected F508del-FRT cells by appr 6-fold with an EC50 of 25 nM.
In Vivo: Ivacaftor (1-200 mg/kg, p.o.) exhibits good oral bioavailability in rat.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | FDA-Approved Drug Library | Autophagy Compound Library | Drug Repurposing Compound Library | Endocrinology Compound Library | Anti-COVID-19 Compound Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Rare Diseases Drug Library | Children’s Drug Library | EMA-Approved Drug Library | Human Metabolite Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Cell Death Library | Lumacaftor | Glibenclamide | CFTR(inh)-172 | Tezacaftor | Ataluren | Elexacaftor | GlyH-101 | (R)-BPO-27 | Nesolicaftor | IOWH-032 | Posenacaftor sodium | SRI-41315 | GLPG1837 | Navocaftor | PPQ-102 | Cavosonstat | Galicaftor | Bamocaftor | 5,7,4'-Trimethoxyflavone | Icenticaftor | KM11060 | GLPG2451 | Olacaftor | SRI-37240 | Chromanol 293B | NJH-2-057 | CFTR corrector 2 | Crinecerfont hydrochloride | K41498 TFA
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料


















